Position in BCRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$8,670
+$6,757 QoQ
Shares Held
867
+331.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#283
of 316 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROTHSCHILD INVESTMENT LLC holds $2,410,092 across 43 Drug Manufacturers - Specialty & Generic names. BCRX ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,066 | $853,823 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
19,966 | $320,054 | |
| 3 | VTRS |
Viatris Inc
|
17,747 | $281,822 | |
| 4 | ZTS |
Zoetis Inc.
|
3,502 | $251,653 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
350 | $189,640 | |
| 6 | PRGO |
PERRIGO Co plc
|
17,438 | $181,180 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,504 | $84,835 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,301 | $74,450 |
All Filings in BCRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,670 | 867 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,913 | 201 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,575 | 202 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,314 | 305 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $3,449 | 385 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,037 | 405 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,880 | 250 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,406 | 185 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $679 | 110 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $127 | 25 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||